![](/img/cover-not-exists.png)
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1–42 antibodies in Alzheimer's disease patients
Elisa Conti, Gloria Galimberti, Lucio Tremolizzo, Alessandro Masetto, Diletta Cereda, Clara Zanchi, Fabrizio Piazza, Marco Casati, Valeria Isella, Ildebrando Appollonio, Carlo FerrareseVolume:
486
Year:
2010
Language:
english
DOI:
10.1016/j.neulet.2010.09.050
File:
PDF, 174 KB
english, 2010